0
     

Report Added
Report already added
Drug Delivery in Cancer Market, Global Outlook and Forecast 2022-2028

Drug Delivery in Cancer Market, Global Outlook and Forecast 2022-2028

This report contains market size and forecasts of Drug Delivery in Cancer in Global, including the following market information:

Global Drug Delivery in Cancer Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Drug Delivery in Cancer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Liposomes Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drug Delivery in Cancer include Amgen, Teva, UCB (Union Chimique Belge), Roche, Celgene, Sanofi, Merck, Johnson & Johnson and Takeda, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drug Delivery in Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Drug Delivery in Cancer Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Drug Delivery in Cancer Market Segment Percentages, by Type, 2021 (%)
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others
Global Drug Delivery in Cancer Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Drug Delivery in Cancer Market Segment Percentages, by Application, 2021 (%)
Hospitals & Clinic
Cancer Treatment Centers
Others
Global Drug Delivery in Cancer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Drug Delivery in Cancer Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drug Delivery in Cancer revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Drug Delivery in Cancer revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Teva
UCB (Union Chimique Belge)
Roche
Celgene
Sanofi
Merck
Johnson & Johnson
Takeda
Gilead Sciences
Pfizer
Dr Reddy
Samyang Biopharmaceuticals
Tolmar
Astellas
AMAG Pharmaceuticals
AstraZeneca
AbbVie
Novartis
Aspen
Shire (Baxalta)
Breckenridge Pharmaceuticals
Galen Pharmaceuticals
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Drug Delivery in Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drug Delivery in Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drug Delivery in Cancer Overall Market Size
2.1 Global Drug Delivery in Cancer Market Size: 2021 VS 2028
2.2 Global Drug Delivery in Cancer Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drug Delivery in Cancer Players in Global Market
3.2 Top Global Drug Delivery in Cancer Companies Ranked by Revenue
3.3 Global Drug Delivery in Cancer Revenue by Companies
3.4 Top 3 and Top 5 Drug Delivery in Cancer Companies in Global Market, by Revenue in 2021
3.5 Global Companies Drug Delivery in Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drug Delivery in Cancer Players in Global Market
3.6.1 List of Global Tier 1 Drug Delivery in Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Drug Delivery in Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Drug Delivery in Cancer Market Size Markets, 2021 & 2028
4.1.2 Liposomes
4.1.3 PEGylated Proteins & Polypeptides
4.1.4 Polymer Nanoparticle
4.1.5 Protein–drug Conjugates
4.1.6 Others
4.2 By Type - Global Drug Delivery in Cancer Revenue & Forecasts
4.2.1 By Type - Global Drug Delivery in Cancer Revenue, 2017-2022
4.2.2 By Type - Global Drug Delivery in Cancer Revenue, 2023-2028
4.2.3 By Type - Global Drug Delivery in Cancer Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drug Delivery in Cancer Market Size, 2021 & 2028
5.1.2 Hospitals & Clinic
5.1.3 Cancer Treatment Centers
5.1.4 Others
5.2 By Application - Global Drug Delivery in Cancer Revenue & Forecasts
5.2.1 By Application - Global Drug Delivery in Cancer Revenue, 2017-2022
5.2.2 By Application - Global Drug Delivery in Cancer Revenue, 2023-2028
5.2.3 By Application - Global Drug Delivery in Cancer Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Drug Delivery in Cancer Market Size, 2021 & 2028
6.2 By Region - Global Drug Delivery in Cancer Revenue & Forecasts
6.2.1 By Region - Global Drug Delivery in Cancer Revenue, 2017-2022
6.2.2 By Region - Global Drug Delivery in Cancer Revenue, 2023-2028
6.2.3 By Region - Global Drug Delivery in Cancer Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Drug Delivery in Cancer Revenue, 2017-2028
6.3.2 US Drug Delivery in Cancer Market Size, 2017-2028
6.3.3 Canada Drug Delivery in Cancer Market Size, 2017-2028
6.3.4 Mexico Drug Delivery in Cancer Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Drug Delivery in Cancer Revenue, 2017-2028
6.4.2 Germany Drug Delivery in Cancer Market Size, 2017-2028
6.4.3 France Drug Delivery in Cancer Market Size, 2017-2028
6.4.4 U.K. Drug Delivery in Cancer Market Size, 2017-2028
6.4.5 Italy Drug Delivery in Cancer Market Size, 2017-2028
6.4.6 Russia Drug Delivery in Cancer Market Size, 2017-2028
6.4.7 Nordic Countries Drug Delivery in Cancer Market Size, 2017-2028
6.4.8 Benelux Drug Delivery in Cancer Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Drug Delivery in Cancer Revenue, 2017-2028
6.5.2 China Drug Delivery in Cancer Market Size, 2017-2028
6.5.3 Japan Drug Delivery in Cancer Market Size, 2017-2028
6.5.4 South Korea Drug Delivery in Cancer Market Size, 2017-2028
6.5.5 Southeast Asia Drug Delivery in Cancer Market Size, 2017-2028
6.5.6 India Drug Delivery in Cancer Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Drug Delivery in Cancer Revenue, 2017-2028
6.6.2 Brazil Drug Delivery in Cancer Market Size, 2017-2028
6.6.3 Argentina Drug Delivery in Cancer Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drug Delivery in Cancer Revenue, 2017-2028
6.7.2 Turkey Drug Delivery in Cancer Market Size, 2017-2028
6.7.3 Israel Drug Delivery in Cancer Market Size, 2017-2028
6.7.4 Saudi Arabia Drug Delivery in Cancer Market Size, 2017-2028
6.7.5 UAE Drug Delivery in Cancer Market Size, 2017-2028
7 Players Profiles
7.1 Amgen
7.1.1 Amgen Corporate Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Drug Delivery in Cancer Major Product Offerings
7.1.4 Amgen Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.1.5 Amgen Key News
7.2 Teva
7.2.1 Teva Corporate Summary
7.2.2 Teva Business Overview
7.2.3 Teva Drug Delivery in Cancer Major Product Offerings
7.2.4 Teva Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.2.5 Teva Key News
7.3 UCB (Union Chimique Belge)
7.3.1 UCB (Union Chimique Belge) Corporate Summary
7.3.2 UCB (Union Chimique Belge) Business Overview
7.3.3 UCB (Union Chimique Belge) Drug Delivery in Cancer Major Product Offerings
7.3.4 UCB (Union Chimique Belge) Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.3.5 UCB (Union Chimique Belge) Key News
7.4 Roche
7.4.1 Roche Corporate Summary
7.4.2 Roche Business Overview
7.4.3 Roche Drug Delivery in Cancer Major Product Offerings
7.4.4 Roche Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.4.5 Roche Key News
7.5 Celgene
7.5.1 Celgene Corporate Summary
7.5.2 Celgene Business Overview
7.5.3 Celgene Drug Delivery in Cancer Major Product Offerings
7.5.4 Celgene Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.5.5 Celgene Key News
7.6 Sanofi
7.6.1 Sanofi Corporate Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Drug Delivery in Cancer Major Product Offerings
7.6.4 Sanofi Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.6.5 Sanofi Key News
7.7 Merck
7.7.1 Merck Corporate Summary
7.7.2 Merck Business Overview
7.7.3 Merck Drug Delivery in Cancer Major Product Offerings
7.7.4 Merck Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.7.5 Merck Key News
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Corporate Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Drug Delivery in Cancer Major Product Offerings
7.8.4 Johnson & Johnson Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.8.5 Johnson & Johnson Key News
7.9 Takeda
7.9.1 Takeda Corporate Summary
7.9.2 Takeda Business Overview
7.9.3 Takeda Drug Delivery in Cancer Major Product Offerings
7.9.4 Takeda Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.9.5 Takeda Key News
7.10 Gilead Sciences
7.10.1 Gilead Sciences Corporate Summary
7.10.2 Gilead Sciences Business Overview
7.10.3 Gilead Sciences Drug Delivery in Cancer Major Product Offerings
7.10.4 Gilead Sciences Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.10.5 Gilead Sciences Key News
7.11 Pfizer
7.11.1 Pfizer Corporate Summary
7.11.2 Pfizer Business Overview
7.11.3 Pfizer Drug Delivery in Cancer Major Product Offerings
7.11.4 Pfizer Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.11.5 Pfizer Key News
7.12 Dr Reddy
7.12.1 Dr Reddy Corporate Summary
7.12.2 Dr Reddy Business Overview
7.12.3 Dr Reddy Drug Delivery in Cancer Major Product Offerings
7.12.4 Dr Reddy Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.12.5 Dr Reddy Key News
7.13 Samyang Biopharmaceuticals
7.13.1 Samyang Biopharmaceuticals Corporate Summary
7.13.2 Samyang Biopharmaceuticals Business Overview
7.13.3 Samyang Biopharmaceuticals Drug Delivery in Cancer Major Product Offerings
7.13.4 Samyang Biopharmaceuticals Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.13.5 Samyang Biopharmaceuticals Key News
7.14 Tolmar
7.14.1 Tolmar Corporate Summary
7.14.2 Tolmar Business Overview
7.14.3 Tolmar Drug Delivery in Cancer Major Product Offerings
7.14.4 Tolmar Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.14.5 Tolmar Key News
7.15 Astellas
7.15.1 Astellas Corporate Summary
7.15.2 Astellas Business Overview
7.15.3 Astellas Drug Delivery in Cancer Major Product Offerings
7.15.4 Astellas Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.15.5 Astellas Key News
7.16 AMAG Pharmaceuticals
7.16.1 AMAG Pharmaceuticals Corporate Summary
7.16.2 AMAG Pharmaceuticals Business Overview
7.16.3 AMAG Pharmaceuticals Drug Delivery in Cancer Major Product Offerings
7.16.4 AMAG Pharmaceuticals Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.16.5 AMAG Pharmaceuticals Key News
7.17 AstraZeneca
7.17.1 AstraZeneca Corporate Summary
7.17.2 AstraZeneca Business Overview
7.17.3 AstraZeneca Drug Delivery in Cancer Major Product Offerings
7.17.4 AstraZeneca Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.17.5 AstraZeneca Key News
7.18 AbbVie
7.18.1 AbbVie Corporate Summary
7.18.2 AbbVie Business Overview
7.18.3 AbbVie Drug Delivery in Cancer Major Product Offerings
7.18.4 AbbVie Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.18.5 AbbVie Key News
7.19 Novartis
7.19.1 Novartis Corporate Summary
7.19.2 Novartis Business Overview
7.19.3 Novartis Drug Delivery in Cancer Major Product Offerings
7.19.4 Novartis Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.19.5 Novartis Key News
7.20 Aspen
7.20.1 Aspen Corporate Summary
7.20.2 Aspen Business Overview
7.20.3 Aspen Drug Delivery in Cancer Major Product Offerings
7.20.4 Aspen Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.20.5 Aspen Key News
7.21 Shire (Baxalta)
7.21.1 Shire (Baxalta) Corporate Summary
7.21.2 Shire (Baxalta) Business Overview
7.21.3 Shire (Baxalta) Drug Delivery in Cancer Major Product Offerings
7.21.4 Shire (Baxalta) Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.21.5 Shire (Baxalta) Key News
7.22 Breckenridge Pharmaceuticals
7.22.1 Breckenridge Pharmaceuticals Corporate Summary
7.22.2 Breckenridge Pharmaceuticals Business Overview
7.22.3 Breckenridge Pharmaceuticals Drug Delivery in Cancer Major Product Offerings
7.22.4 Breckenridge Pharmaceuticals Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.22.5 Breckenridge Pharmaceuticals Key News
7.23 Galen Pharmaceuticals
7.23.1 Galen Pharmaceuticals Corporate Summary
7.23.2 Galen Pharmaceuticals Business Overview
7.23.3 Galen Pharmaceuticals Drug Delivery in Cancer Major Product Offerings
7.23.4 Galen Pharmaceuticals Drug Delivery in Cancer Revenue in Global Market (2017-2022)
7.23.5 Galen Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Drug Delivery in Cancer Market Opportunities & Trends in Global Market
Table 2. Drug Delivery in Cancer Market Drivers in Global Market
Table 3. Drug Delivery in Cancer Market Restraints in Global Market
Table 4. Key Players of Drug Delivery in Cancer in Global Market
Table 5. Top Drug Delivery in Cancer Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Drug Delivery in Cancer Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Drug Delivery in Cancer Revenue Share by Companies, 2017-2022
Table 8. Global Companies Drug Delivery in Cancer Product Type
Table 9. List of Global Tier 1 Drug Delivery in Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drug Delivery in Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Drug Delivery in Cancer Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Drug Delivery in Cancer Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Drug Delivery in Cancer Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Drug Delivery in Cancer Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Drug Delivery in Cancer Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Drug Delivery in Cancer Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Drug Delivery in Cancer Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Drug Delivery in Cancer Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Drug Delivery in Cancer Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Drug Delivery in Cancer Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Drug Delivery in Cancer Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Drug Delivery in Cancer Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Drug Delivery in Cancer Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Drug Delivery in Cancer Revenue, (US$, Mn), 2023-2028
Table 30. Amgen Corporate Summary
Table 31. Amgen Drug Delivery in Cancer Product Offerings
Table 32. Amgen Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 33. Teva Corporate Summary
Table 34. Teva Drug Delivery in Cancer Product Offerings
Table 35. Teva Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 36. UCB (Union Chimique Belge) Corporate Summary
Table 37. UCB (Union Chimique Belge) Drug Delivery in Cancer Product Offerings
Table 38. UCB (Union Chimique Belge) Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 39. Roche Corporate Summary
Table 40. Roche Drug Delivery in Cancer Product Offerings
Table 41. Roche Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 42. Celgene Corporate Summary
Table 43. Celgene Drug Delivery in Cancer Product Offerings
Table 44. Celgene Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 45. Sanofi Corporate Summary
Table 46. Sanofi Drug Delivery in Cancer Product Offerings
Table 47. Sanofi Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 48. Merck Corporate Summary
Table 49. Merck Drug Delivery in Cancer Product Offerings
Table 50. Merck Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 51. Johnson & Johnson Corporate Summary
Table 52. Johnson & Johnson Drug Delivery in Cancer Product Offerings
Table 53. Johnson & Johnson Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 54. Takeda Corporate Summary
Table 55. Takeda Drug Delivery in Cancer Product Offerings
Table 56. Takeda Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 57. Gilead Sciences Corporate Summary
Table 58. Gilead Sciences Drug Delivery in Cancer Product Offerings
Table 59. Gilead Sciences Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 60. Pfizer Corporate Summary
Table 61. Pfizer Drug Delivery in Cancer Product Offerings
Table 62. Pfizer Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 63. Dr Reddy Corporate Summary
Table 64. Dr Reddy Drug Delivery in Cancer Product Offerings
Table 65. Dr Reddy Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 66. Samyang Biopharmaceuticals Corporate Summary
Table 67. Samyang Biopharmaceuticals Drug Delivery in Cancer Product Offerings
Table 68. Samyang Biopharmaceuticals Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 69. Tolmar Corporate Summary
Table 70. Tolmar Drug Delivery in Cancer Product Offerings
Table 71. Tolmar Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 72. Astellas Corporate Summary
Table 73. Astellas Drug Delivery in Cancer Product Offerings
Table 74. Astellas Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 75. AMAG Pharmaceuticals Corporate Summary
Table 76. AMAG Pharmaceuticals Drug Delivery in Cancer Product Offerings
Table 77. AMAG Pharmaceuticals Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 78. AstraZeneca Corporate Summary
Table 79. AstraZeneca Drug Delivery in Cancer Product Offerings
Table 80. AstraZeneca Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 81. AbbVie Corporate Summary
Table 82. AbbVie Drug Delivery in Cancer Product Offerings
Table 83. AbbVie Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 84. Novartis Corporate Summary
Table 85. Novartis Drug Delivery in Cancer Product Offerings
Table 86. Novartis Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 87. Aspen Corporate Summary
Table 88. Aspen Drug Delivery in Cancer Product Offerings
Table 89. Aspen Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 90. Shire (Baxalta) Corporate Summary
Table 91. Shire (Baxalta) Drug Delivery in Cancer Product Offerings
Table 92. Shire (Baxalta) Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 93. Breckenridge Pharmaceuticals Corporate Summary
Table 94. Breckenridge Pharmaceuticals Drug Delivery in Cancer Product Offerings
Table 95. Breckenridge Pharmaceuticals Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)
Table 96. Galen Pharmaceuticals Corporate Summary
Table 97. Galen Pharmaceuticals Drug Delivery in Cancer Product Offerings
Table 98. Galen Pharmaceuticals Drug Delivery in Cancer Revenue (US$, Mn), (2017-2022)

List of Figures
Figure 1. Drug Delivery in Cancer Segment by Type in 2021
Figure 2. Drug Delivery in Cancer Segment by Application in 2021
Figure 3. Global Drug Delivery in Cancer Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Drug Delivery in Cancer Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Drug Delivery in Cancer Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drug Delivery in Cancer Revenue in 2021
Figure 8. By Type - Global Drug Delivery in Cancer Revenue Market Share, 2017-2028
Figure 9. By Application - Global Drug Delivery in Cancer Revenue Market Share, 2017-2028
Figure 10. By Region - Global Drug Delivery in Cancer Revenue Market Share, 2017-2028
Figure 11. By Country - North America Drug Delivery in Cancer Revenue Market Share, 2017-2028
Figure 12. US Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Drug Delivery in Cancer Revenue Market Share, 2017-2028
Figure 16. Germany Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2028
Figure 17. France Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Drug Delivery in Cancer Revenue Market Share, 2017-2028
Figure 24. China Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2028
Figure 28. India Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Drug Delivery in Cancer Revenue Market Share, 2017-2028
Figure 30. Brazil Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Drug Delivery in Cancer Revenue Market Share, 2017-2028
Figure 33. Turkey Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Drug Delivery in Cancer Revenue, (US$, Mn), 2017-2028
Figure 37. Amgen Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. UCB (Union Chimique Belge) Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Roche Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Celgene Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sanofi Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Johnson & Johnson Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Takeda Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Gilead Sciences Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Pfizer Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Dr Reddy Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Samyang Biopharmaceuticals Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Tolmar Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Astellas Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. AMAG Pharmaceuticals Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. AstraZeneca Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. AbbVie Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Novartis Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Aspen Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Shire (Baxalta) Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Breckenridge Pharmaceuticals Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Galen Pharmaceuticals Drug Delivery in Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Report Title: Drug Delivery in Cancer Market, Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Artificial Intelligence in Medical Diagnostics Market By Component (Software, Services), Specialty (Radiology, Cardiology, Neurology, Obstetrics/Gynecology, Oncology), Modality (MRI, CT, X-ray, Ultrasound), End User - Global Forecast to 2029

Artificial Intelligence in Medical Diagnostics Market By Component (Software, Services), Specialty (Radiology, Cardiology, Neurology, Obstetrics/Gynecology, Oncology), Modality (MRI, CT, X-ray, Ultrasound), End User - Global Forecast to 2029

HLA Typing Market by Product (Instruments, Software), Technology (Molecular [PCR, Sequencing [Sangers, NGS]], Serology), Application (Diagnostics [Cross Match, Cancer, Infectious Disease, Transfusion], Research), End User, and Geography - Forecast to 2029

HLA Typing Market by Product (Instruments, Software), Technology (Molecular [PCR, Sequencing [Sangers, NGS]], Serology), Application (Diagnostics [Cross Match, Cancer, Infectious Disease, Transfusion], Research), End User, and Geography - Forecast to 2029

U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology), End User (Pharma Companies, Providers) - Forecast to 2029

U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology), End User (Pharma Companies, Providers) - Forecast to 2029

Medical Aesthetics Market by Product (Facial Aesthetics, Body Contouring, Cosmetic Implant, Physician Dispensed Cosmeceuticals, Skin Aesthetic, Thread Lift), End User (Hospitals, Clinics, & Medical Spas, Beauty Centers, & Home Care) - Forecast to 2029

Medical Aesthetics Market by Product (Facial Aesthetics, Body Contouring, Cosmetic Implant, Physician Dispensed Cosmeceuticals, Skin Aesthetic, Thread Lift), End User (Hospitals, Clinics, & Medical Spas, Beauty Centers, & Home Care) - Forecast to 2029

United Kingdom Hospital Market, By Ownership (Public v/s Private), By Type (General, Multispecialty, Specialty), By Type of Services (In-Patient Services v/s Out-Patient Services), By Bed Capacity (Above 500, 100-500, up to 100), By Region, Competition, Forecast & Opportunities, 2017-2027F

United Kingdom Hospital Market, By Ownership (Public v/s Private), By Type (General, Multispecialty, Specialty), By Type of Services (In-Patient Services v/s Out-Patient Services), By Bed Capacity (Above 500, 100-500, up to 100), By Region, Competition, Forecast & Opportunities, 2017-2027F

Saudi Arabia Magnetic Resonance Imaging Market, By Field Strength (High-Field MRI Systems, Low-to-Mid Field MRI Systems, Very-High-Field MRI Systems), By Type (Fixed v/s Mobile), By Architecture (Closed v/s Open), By Source (Import v/s Domestic), By Application (Brain and Neurological, Oncology, Spine and Musculoskeletal, Abdominal, Cardiac & Others), By End User (Hospitals, Imaging Centers, Ambulatory Surgical Centers & Others), By Region, Competition, Forecast & Opportunities, 2017-2027F

Saudi Arabia Magnetic Resonance Imaging Market, By Field Strength (High-Field MRI Systems, Low-to-Mid Field MRI Systems, Very-High-Field MRI Systems), By Type (Fixed v/s Mobile), By Architecture (Closed v/s Open), By Source (Import v/s Domestic), By Application (Brain and Neurological, Oncology, Spine and Musculoskeletal, Abdominal, Cardiac & Others), By End User (Hospitals, Imaging Centers, Ambulatory Surgical Centers & Others), By Region, Competition, Forecast & Opportunities, 2017-2027F